• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌肝转移中的肝细胞外基质

Liver Extracellular Matrix in Colorectal Liver Metastasis.

作者信息

Morabito Marika, Thibodot Pauline, Gigandet Anthony, Compagnon Philippe, Toso Christian, Berishvili Ekaterine, Lacotte Stéphanie, Peloso Andrea

机构信息

General, Emergency and Transplant Surgery Department, ASST Settelaghi, University Hospital and Faculty of Medicine of Insubria, 21100 Varese, Italy.

Hepato-Biliary Center, Paul-Brousse Hospital, Assistance Publique-Hôpitaux de Paris, 94800 Villejuif, France.

出版信息

Cancers (Basel). 2025 Mar 12;17(6):953. doi: 10.3390/cancers17060953.

DOI:10.3390/cancers17060953
PMID:40149289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11939972/
Abstract

The liver is the most common site of metastasis of colorectal cancer (CRC), and colorectal liver metastasis is one of the major causes of CRC-related deaths worldwide. The tumor microenvironment, particularly the extracellular matrix (ECM), plays a critical role in CRC metastasis and chemoresistance. Based on findings from clinical and basic research, this review attempts to offer a complete understanding of the role of the ECM in colorectal liver metastasis and to suggest potential ways for therapeutic intervention. First, the ECMs' role in regulating cancer cell fate is explored. We then discuss the hepatic ECM fingerprint and its influence on the metastatic behavior of CRC cells, highlighting key molecular interactions that promote metastasis. In addition, we examine how changes in the ECM within the metastatic niche contribute to chemoresistance, focusing on ECM remodeling by ECM stiffening and the activation of specific signaling pathways. Understanding these mechanisms is crucial for the development of novel strategies to overcome metastasis and improve outcomes for CRC patients.

摘要

肝脏是结直肠癌(CRC)最常见的转移部位,结直肠癌肝转移是全球CRC相关死亡的主要原因之一。肿瘤微环境,尤其是细胞外基质(ECM),在CRC转移和化疗耐药中起关键作用。基于临床和基础研究的结果,本综述试图全面了解ECM在结直肠癌肝转移中的作用,并提出潜在的治疗干预方法。首先,探讨ECM在调节癌细胞命运中的作用。然后,我们讨论肝脏ECM指纹及其对CRC细胞转移行为的影响,突出促进转移的关键分子相互作用。此外,我们研究转移微环境中ECM的变化如何导致化疗耐药,重点关注ECM硬化和特定信号通路激活引起的ECM重塑。了解这些机制对于开发克服转移的新策略和改善CRC患者的预后至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d266/11939972/abfe50731694/cancers-17-00953-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d266/11939972/96b9d2f849d6/cancers-17-00953-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d266/11939972/abfe50731694/cancers-17-00953-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d266/11939972/96b9d2f849d6/cancers-17-00953-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d266/11939972/abfe50731694/cancers-17-00953-g002.jpg

相似文献

1
Liver Extracellular Matrix in Colorectal Liver Metastasis.结直肠癌肝转移中的肝细胞外基质
Cancers (Basel). 2025 Mar 12;17(6):953. doi: 10.3390/cancers17060953.
2
Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer.在一位结直肠癌患者的三个复发性肝转移灶中,细胞外基质蛋白的差异调节。
Clin Exp Metastasis. 2020 Dec;37(6):649-656. doi: 10.1007/s10585-020-10058-8. Epub 2020 Oct 24.
3
The lncRNA MIR181A1HG in extracellular vesicles derived from highly metastatic colorectal cancer cells promotes liver metastasis by remodeling the extracellular matrix and recruiting myeloid-derived suppressor cells.源自高转移性结肠癌细胞的细胞外囊泡中的长链非编码RNA MIR181A1HG通过重塑细胞外基质和招募髓源性抑制细胞促进肝转移。
Cell Biosci. 2025 Feb 19;15(1):23. doi: 10.1186/s13578-025-01365-2.
4
Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment.高转移性结直肠癌细胞释放富含 miR-181a-5p 的细胞外囊泡通过激活肝星状细胞和重塑肿瘤微环境促进肝转移。
J Extracell Vesicles. 2022 Jan;11(1):e12186. doi: 10.1002/jev2.12186.
5
Colorectal cancer cells-derived exosomal miR-188-3p promotes liver metastasis by creating a pre-metastatic niche via activation of hepatic stellate cells.结直肠癌细胞衍生的外泌体miR-188-3p通过激活肝星状细胞形成前转移微环境来促进肝转移。
J Transl Med. 2025 Mar 25;23(1):369. doi: 10.1186/s12967-025-06334-4.
6
Therapeutic Potentials of MiRNA for Colorectal Cancer Liver Metastasis Treatment: A Narrative Review.用于结直肠癌肝转移治疗的微小RNA的治疗潜力:一篇叙述性综述
Iran J Med Sci. 2025 Apr 1;50(4):202-219. doi: 10.30476/ijms.2024.102910.3622. eCollection 2025 Apr.
7
Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.卵泡抑素样蛋白 3 与淋巴结转移相关,并可作为结直肠癌细胞外基质重塑的生物标志物。
Front Immunol. 2021 Jul 16;12:717505. doi: 10.3389/fimmu.2021.717505. eCollection 2021.
8
Cancer-secreted exosomal miR-1246 promotes colorectal cancer liver metastasis by activating hepatic stellate cells.癌症分泌的外泌体miR-1246通过激活肝星状细胞促进结直肠癌肝转移。
Mol Med. 2025 Feb 20;31(1):68. doi: 10.1186/s10020-025-01112-w.
9
Mfsd2a suppresses colorectal cancer progression and liver metastasis via the S100A14/STAT3 axis.Mfsd2a通过S100A14/STAT3轴抑制结直肠癌进展和肝转移。
J Transl Med. 2025 Jan 13;23(1):59. doi: 10.1186/s12967-024-05994-y.
10
Targeting circ-0034880-enriched tumor extracellular vesicles to impede SPP1CD206 pro-tumor macrophages mediated pre-metastatic niche formation in colorectal cancer liver metastasis.靶向富含 circ-0034880 的肿瘤细胞外囊泡以抑制 SPP1CD206 促肿瘤巨噬细胞介导的结直肠癌肝转移前转移龛形成。
Mol Cancer. 2024 Aug 20;23(1):168. doi: 10.1186/s12943-024-02086-9.

引用本文的文献

1
Protocol for spatial characterization of ECM collagen-GAG in CRC tumor microenvironment.结直肠癌肿瘤微环境中细胞外基质胶原蛋白-糖胺聚糖空间特征分析方案。
bioRxiv. 2025 Jun 27:2025.06.25.661355. doi: 10.1101/2025.06.25.661355.

本文引用的文献

1
CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance.CRISPR筛选和细胞系IC50数据揭示了曲美替尼耐药的新关键基因。
Clin Exp Med. 2024 Dec 21;25(1):21. doi: 10.1007/s10238-024-01538-2.
2
Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN).使用全球癌症统计数据(GLOBOCAN)对2020年至2022年期间的癌症概况进行比较研究。
J Natl Cancer Cent. 2024 May 7;4(2):128-134. doi: 10.1016/j.jncc.2024.05.001. eCollection 2024 Jun.
3
Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.
基质金属蛋白酶-2 蛋白和基质金属蛋白酶-9 蛋白在结直肠癌中的预后价值:一项荟萃分析。
BMC Cancer. 2024 Aug 29;24(1):1065. doi: 10.1186/s12885-024-12775-9.
4
The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics.细胞外基质重塑与癌症治疗的相互作用。
Cancer Discov. 2024 Aug 2;14(8):1375-1388. doi: 10.1158/2159-8290.CD-24-0002.
5
Collagen as the extracellular matrix biomaterials in the arena of medical sciences.胶原蛋白作为细胞外基质生物材料在医学科学领域。
Tissue Cell. 2024 Oct;90:102497. doi: 10.1016/j.tice.2024.102497. Epub 2024 Jul 24.
6
Current Applications and Future Directions of Circulating Tumor Cells in Colorectal Cancer Recurrence.循环肿瘤细胞在结直肠癌复发中的当前应用及未来方向
Cancers (Basel). 2024 Jun 24;16(13):2316. doi: 10.3390/cancers16132316.
7
TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities.转化生长因子-β(TGF-β)调节结直肠癌中的信号通路:新的潜在治疗机会。
Int J Mol Sci. 2024 Jul 5;25(13):7400. doi: 10.3390/ijms25137400.
8
Genome wide identification of novel DNA methylation driven prognostic markers in colorectal cancer.全基因组鉴定结直肠癌中新的 DNA 甲基化驱动的预后标志物。
Sci Rep. 2024 Jul 8;14(1):15654. doi: 10.1038/s41598-024-60351-9.
9
Cancer treatments: Past, present, and future.癌症治疗:过去、现在和未来。
Cancer Genet. 2024 Aug;286-287:18-24. doi: 10.1016/j.cancergen.2024.06.002. Epub 2024 Jun 17.
10
SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1.SP1 诱导的 circ_0017552 通过上调 NET1 调节结肠癌细胞增殖和凋亡。
Cancer Genet. 2024 Aug;286-287:1-10. doi: 10.1016/j.cancergen.2024.05.002. Epub 2024 May 12.